Scientists Drs. Alyson Kelvin and Angela Rasmussen from the University of Saskatchewan’s Vaccine and Infectious Disease Organization (VIDO) have received $1-million in total funding to study mpox from the Canadian Institutes of Health Research.
[University of Saskatchewan]
